Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM173A | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | BMP8B | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | KBTBD8 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | GPRASP2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | SPATS2L | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | ZC3H12B | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | B3GNT7 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | CYB5R3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | IL33 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | FAM72D | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |